We are live on ! Find out more
DC

Diametric Capital Portfolio holdings

AUM $948M
1-Year Est. Return 47.49%
This Fund
S&P 500
This Quarter Est. Return
+26.17%
1 Year Est. Return
+47.49%
3 Year Est. Return
+174.7%
5 Year Est. Return
+276.83%
10 Year Est. Return
AUM
$948M
AUM Growth
+$564M
Cap. Flow
+$473M
Cap. Flow %
49.87%
Top 10 Hldgs %
39.41%
Holding
760
New
287
Increased
124
Reduced
59
Closed
286

Sector Composition

Rank Sector Weight
1 Miscellaneous 30.11%
2 Healthcare 15.56%
3 Technology 12.71%
4 Consumer Discretionary 11.1%
5 Industrials 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OMCL icon
626
Omnicell
OMCL
$1.57B
-7,043
Closed -$235K
ONDS icon
627
Ondas Inc
ONDS
$4.35B
-29,660
Closed -$268K
OVID icon
628
Ovid Therapeutics
OVID
$547M
-43,262
Closed -$96K
PALI icon
629
Palisade Bio
PALI
$364M
-51,874
Closed -$90.8K
PAY icon
630
Paymentus
PAY
$4.56B
-18,738
Closed -$476K
PBI icon
631
Pitney Bowes
PBI
$2.39B
-157,828
Closed -$1.74M
PD icon
632
PagerDuty
PD
$1.07B
-57,973
Closed -$360K
PED icon
633
PEDEVCO
PED
$191M
-12,836
Closed -$205K
PEN icon
634
Penumbra
PEN
$12.7B
-4,466
Closed -$1.47M
PENN icon
635
PENN Entertainment
PENN
$2.29B
-323,845
Closed -$4.87M
PEPG icon
636
PepGen
PEPG
$215M
-15,221
Closed -$26.9K
PH icon
637
Parker-Hannifin
PH
$121B
-801
Closed -$717K
PLBY icon
638
Playboy Inc
PLBY
$140M
-24,365
Closed -$37K
PLX icon
639
Protalix BioTherapeutics
PLX
$215M
-124,195
Closed -$270K
PRGS icon
640
Progress Software
PRGS
$1.81B
-10,924
Closed -$280K
PRLD icon
641
Prelude Therapeutics
PRLD
$436M
-11,980
Closed -$41K
PROK icon
642
ProKidney
PROK
$420M
-47,827
Closed -$85.6K
PROP icon
643
Prairie Operating Co
PROP
$51.1M
-481,699
Closed -$978K
PSTL
644
Postal Realty Trust
PSTL
$717M
-22,369
Closed -$415K
PTON icon
645
Peloton Interactive
PTON
$2.37B
-265,857
Closed -$1.14M
QGEN icon
646
Qiagen
QGEN
$8.98B
-40,000
Closed -$1.6M
QRVO icon
647
Qorvo
QRVO
$9.07B
-6,344
Closed -$491K
QUIK icon
648
QuickLogic
QUIK
$197M
-32,998
Closed -$310K
RANI icon
649
Rani Therapeutics
RANI
$99.9M
-33,208
Closed -$24.4K
RDZN icon
650
Roadzen
RDZN
$110M
-16,781
Closed -$20.1K

Similar funds

Diametric Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Diametric Capital held 760 positions worth $948M, up 146% from $385M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Diametric Capital deployed $473M of net new capital in Q2 2026, opening 287 new positions and adding to 124 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 316,249 shares worth $236M.

By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 3.9% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Forgent Power Solutions, an estimated $5.62M trimmed.

  • Diametric Capital's largest Q2 2026 buy was State Street SPDR S&P 500 ETF Trust: 316,249 shares worth $236M.
  • Diametric Capital added most to Invesco S&P 500 Low Volatility ETF in Q2 2026, an estimated $13.7M increase.
  • Diametric Capital's biggest Q2 2026 reduction was Forgent Power Solutions, cutting an estimated $5.62M.
  • Diametric Capital fully exited PENN Entertainment in Q2 2026, selling an estimated $4.87M.
  • Diametric Capital's ten largest holdings make up 39% of its $948M portfolio in Q2 2026.
  • Diametric Capital opened 287 new positions and closed 286 in Q2 2026.
  • Diametric Capital's portfolio value rose 146% quarter-over-quarter to $948M.

Based on Diametric Capital's 13F filing for Q2 2026, filed 14 Aug 2026.